前列腺MRI-TRUS融合活检:当前技术综述
前列腺癌筛查阳性患者常规行TRUS引导系统活检,但敏感性不足,尤其前部、尖部及大体积腺体肿瘤。MRI-TRUS融合活检结合MRI靶向与TRUS实时引导,越来越多用于临床高度怀疑前列腺癌且既往系统活检阴性者。本文综述其当前作用、适应证、工作流程、患者准备、操作及并发症,并比较不同融合平台在软件、活检路径、TRUS采集、校正方式和探头追踪硬件上的差异。
要点
- MRI-TRUS融合活检将MRI靶向与TRUS实时引导结合,用于临床高度怀疑前列腺癌且既往系统活检阴性者。
- 系统活检敏感性不足,尤其对前部前列腺、尖部及大体积腺体肿瘤。
- 不同融合平台在操作软件、活检路径、TRUS采集技术、融合校正方式和探头追踪硬件上存在差异。
核心结论
- MRI-TRUS融合活检结合MRI靶向与TRUS实时引导,越来越多用于临床高度怀疑前列腺癌且既往系统活检阴性的男性。
研究设计与样本
- 综述,描述MRI-TRUS融合活检的当前作用、适应证、工作流程、患者准备、活检操作及并发症,并讨论不同融合平台的技术差异。
诊断标准与关键数值
- 筛查阳性患者行TRUS引导系统活检是当前前列腺癌诊断标准;系统活检敏感性较差,尤其对前部前列腺、尖部及大体积腺体肿瘤。
临床应用与阅片要点
- MRI-TRUS融合活检将MRI靶向与TRUS实时引导结合,应用于临床高度怀疑前列腺癌且既往系统活检阴性的男性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Prostate cancer is the fourth most common cancer and population-based screening programmes are being increasingly adopted worldwide. Screening-positive patients undergo routine transrectal ultrasound (TRUS)-guided systematic biopsy, which is the current diagnostic standard for prostate cancer. However, systematic biopsies suffer from poor sensitivity, especially for the tumors of the anterior prostate and apex as well as in large volume glands. In the past decade, MRI-guided targeted biopsies have come up, which utilize the multiparametric capability of MRI to target lesions for sampling. MRI/TRUS fusion biopsies combine the advantages of MRI-targeting with that of real-time guidance made possible by TRUS. MRI-TRUS fusion biopsies are being increasingly used in men with high clinical suspicion of prostate cancer who have had prior negative systematic biopsies. A large number of fusion biopsy platforms are currently available commercially. Although the basic workflow is similar, there are differences in the operational software, biopsy routes offered, TRUS acquisition technique, type of correction applied at the time of fusion and in the probe tracking hardware. The article describes the current role and indications of MRI-TRUS fusion biopsy followed by a discussion on the workflow, patient preparation, biopsy procedure and complications.
引用
- Das CJ, Razik A, Netaji A, et al. Prostate MRI-TRUS fusion biopsy: a review of the state of the art procedure. Abdom Radiol (NY). 2020. PMID: 31897683. doi:10.1007/s00261-019-02391-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。